Home Newsfeeds Snap CEO Says Snapchat Now Has 750M Monthly Active Users

Snap CEO Says Snapchat Now Has 750M Monthly Active Users

– Investor Day

byHappy Mohamed

February 16, 2023

1 minute read

– Investor Day

Neurogene Reports First Patient Dosed In High-Dose Cohort Of NGN-401 Gene Therapy Clinical Trial For Rett Syndrome

By Benzinga Newsdesk

June 18, 9:28 AM

High-dose NGN-401 has been well-tolerated, and low-dose NGN-401 continues to show a favorable safety profileInterim safety data presented at the International Rett Syndrome Foundation (IRSF) ASCEND SummitNeurogene Inc.

NGNE

RBC Capital Maintains Outperform on Domino’s Pizza, Lowers Price Target to $430

By Benzinga Newsdesk

October 11, 7:37 AM

RBC Capital analyst Christopher Carril maintains Domino's Pizza (NYSE:DPZ) with a Outperform and lowers the price target from $460 to $430.

DPZ

Morgan Stanley Maintains Overweight on PayPal Holdings, Raises Price Target to $135

By Benzinga Newsdesk

October 28, 11:20 AM

Morgan Stanley analyst James Faucette maintains PayPal Holdings (NASDAQ:PYPL) with a Overweight and raises the price target from $134 to $135.

PYPL

Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program

By Lara Goldstein

March 1, 10:30 PM

Canadian clinical-stage psychedelics developer Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) will start trading its Class A common shares following a 4-to-1 stock split towards increasing liquidity.

AGNPF

Snap CEO Says Snapchat Now Has 750M Monthly Active Users

Related Posts

Neurogene Reports First Patient Dosed In High-Dose Cohort Of NGN-401 Gene Therapy Clinical Trial For Rett Syndrome

RBC Capital Maintains Outperform on Domino’s Pizza, Lowers Price Target to $430

Morgan Stanley Maintains Overweight on PayPal Holdings, Raises Price Target to $135

Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program